These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30022769)

  • 61. Left ventricular filling hemodynamics in patients with pulmonary edema and preserved versus reduced left ventricular ejection fraction: a prospective Doppler echocardiographic study.
    Dabbah S; Reisner SA; Aronson D; Agmon Y
    J Am Soc Echocardiogr; 2006 Jun; 19(6):733-43. PubMed ID: 16762750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
    O'Neal WT; Mazur M; Bertoni AG; Bluemke DA; Al-Mallah MH; Lima JAC; Kitzman D; Soliman EZ
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28546456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of Left Ventricular Relaxation and Left Atrial Function in Patients With Heart Failure and Preserved Ejection Fraction Versus Patients With Systemic Hypertension and Healthy Subjects.
    Okura H; Kataoka T; Yoshida K
    Am J Cardiol; 2016 Oct; 118(7):1019-23. PubMed ID: 27515892
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide Metabolites.
    Chirinos JA; Akers SR; Trieu L; Ischiropoulos H; Doulias PT; Tariq A; Vasim I; Koppula MR; Syed AA; Soto-Calderon H; Townsend RR; Cappola TP; Margulies KB; Zamani P
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27742619
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Myocardial adipose deposition and the development of heart failure with preserved ejection fraction.
    Wu CK; Lee JK; Hsu JC; Su MM; Wu YF; Lin TT; Lan CW; Hwang JJ; Lin LY
    Eur J Heart Fail; 2020 Mar; 22(3):445-454. PubMed ID: 31696627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience.
    Hammond MM; Shen C; Li S; Kazi DS; Sabe MA; Garan AR; Markson LJ; Manning WJ; Klein AL; Nagueh SF; Strom JB
    PLoS One; 2020; 15(12):e0244379. PubMed ID: 33351853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between sleep-disordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction.
    Suzuki S; Yoshihisa A; Sato Y; Watanabe S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    ESC Heart Fail; 2018 Jun; 5(3):284-291. PubMed ID: 29460495
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fraction.
    Nauta JF; Hummel YM; van der Meer P; Lam CSP; Voors AA; van Melle JP
    Eur J Heart Fail; 2018 Sep; 20(9):1303-1311. PubMed ID: 29877602
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
    Clin Exp Hypertens; 2020; 42(2):110-117. PubMed ID: 30793983
    [No Abstract]   [Full Text] [Related]  

  • 80. Different determinants of exercise capacity in HFpEF compared to HFrEF.
    Batalli A; Ibrahimi P; Bytyçi I; Ahmeti A; Haliti E; Elezi S; Henein MY; Bajraktari G
    Cardiovasc Ultrasound; 2017 Apr; 15(1):12. PubMed ID: 28446199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.